Karyopharm Therapeutics Inc
SWB:25K
Karyopharm Therapeutics Inc
SWB:25K
Price:
4.74
EUR
1.72%
Market Closed
Market Cap:
€2.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
K
|
Karyopharm Therapeutics Inc
SWB:25K
|
US |
|
H
|
Harmony Gold Mining Company Ltd
DUS:HAM1
|
ZA |
|
D
|
Deutsche Bank AG
BMV:DBN
|
DE |
Wall St Price Targets
25K Price Targets Summary
Karyopharm Therapeutics Inc
Karyopharm Therapeutics Inc
Wall Street analysts forecast 25K stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 25K is 9.2 EUR with a low forecast of 3.75 EUR and a high forecast of 14.92 EUR.
Lowest Forecast
Price Target
3.75
EUR
21% Downside
Average Forecast
Price Target
9.2
EUR
94% Upside
Highest Forecast
Price Target
14.92
EUR
215% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 25K's stock price target?
Price Target
9.2
EUR
9.2
EUR
According to Wall Street analysts, the average 1-year price target for 25K is 9.2 EUR with a low forecast of 3.75 EUR and a high forecast of 14.92 EUR.
What is the Revenue forecast for Karyopharm Therapeutics Inc?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 18%.
